Jessica Hotter Utzig

Jessica Hotter is Senior Global Portfolio Strategy & Operations Lead within Oncology Clinical Operations at Gilead Sciences. She specializes in portfolio strategy, operational intelligence, and clinical trial execution across global oncology programs. Jessica partners closely with executive and cross-functional stakeholders to advance data-driven decision-making, strengthen governance frameworks, optimize portfolio planning, and enhance trial delivery.
Recognized for her ability to translate complexity into clarity, Jessica brings together strategic insight, operational expertise, and cross-functional perspectives to help navigate challenges, drive informed decision-making, and deliver meaningful impact. Known for her collaborative and relationship-centered leadership style, she is deeply passionate about advancing science through clinical research and the opportunity clinical trials provide to extend and improve the lives of patients facing cancer. Her work focuses on innovation, patient-centricity, and the responsible application of artificial intelligence to address evolving challenges in clinical development, accelerate insights, and improve outcomes for patients worldwide.